Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Certainly the impact of this will add value IMHO

<< Previous

Bullboard Posts

Next >>

Comment by Tarbabyon Oct 07, 2024 10:58am

163 Views

Post# 36256049

RE:Certainly the impact of this will add value IMHO

Good work.. I just wish TLT would demonstrate positively that Rutherrin is ssfe to inject into humans. This is still not stated by them. At least inject it into some live animals as a proxy to see what dose is tolerated. Almost all their cancer and virus treatments must hinge on that factor.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant